AbbVie, Inc. (ABBV)
292.80
-1.75
(-0.59%)
USD |
NYSE |
Nov 17, 16:00
291.47
-1.33
(-0.45%)
After-Hours: 20:00
AbbVie Price : 292.80 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 299.98 | 301.20 | 293.97 | 294.55 | 5.494M |
| Nov 13, 2026 | 296.58 | 297.25 | 293.56 | 295.03 | 3.262M |
| Nov 12, 2026 | 299.30 | 300.42 | 294.07 | 294.45 | 4.827M |
| Nov 11, 2026 | 291.36 | 295.46 | 289.72 | 294.98 | 3.262M |
| Nov 10, 2026 | 292.50 | 294.50 | 291.04 | 293.89 | 3.521M |
| Nov 09, 2026 | 293.84 | 294.57 | 289.59 | 293.30 | 5.867M |
| Nov 06, 2026 | 282.27 | 291.73 | 281.07 | 291.31 | 5.041M |
| Nov 05, 2026 | 298.74 | 302.93 | 287.71 | 288.24 | 7.971M |
| Nov 04, 2026 | 293.95 | 295.40 | 283.32 | 294.83 | 8.435M |
| Nov 03, 2026 | 288.69 | 291.32 | 284.70 | 286.00 | 5.368M |
| Nov 02, 2026 | 290.38 | 294.86 | 286.14 | 288.84 | 8.850M |
| Oct 30, 2026 | 292.00 | 298.74 | 291.01 | 294.89 | 6.898M |
| Oct 29, 2026 | 291.00 | 292.67 | 288.04 | 290.79 | 4.329M |
| Oct 28, 2026 | 282.93 | 288.80 | 281.22 | 285.99 | 3.111M |
| Oct 27, 2026 | 283.88 | 287.32 | 283.12 | 286.39 | 3.269M |
| Oct 26, 2026 | 287.05 | 289.59 | 285.18 | 286.74 | 4.516M |
| Oct 23, 2026 | 284.58 | 286.76 | 282.30 | 285.64 | 4.632M |
| Oct 22, 2026 | 284.57 | 285.76 | 278.01 | 285.19 | 6.173M |
| Oct 21, 2026 | 287.63 | 289.00 | 282.15 | 284.80 | 4.395M |
| Oct 20, 2026 | 286.90 | 290.98 | 285.00 | 289.08 | 5.176M |
| Oct 19, 2026 | 284.23 | 287.93 | 282.59 | 282.68 | 4.172M |
| Oct 16, 2026 | 283.61 | 286.64 | 282.96 | 285.42 | 5.777M |
| Oct 15, 2026 | 288.28 | 291.40 | 282.81 | 283.40 | 7.622M |
| Oct 14, 2026 | 277.00 | 285.40 | 275.97 | 283.48 | 5.633M |
| Oct 13, 2026 | 283.29 | 283.43 | 273.70 | 274.36 | 6.410M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 170.43 |
| Regeneron Pharmaceuticals, Inc. | 957.91 |
| Biogen, Inc. | 250.79 |
| Amgen, Inc. | 457.91 |
| REGENXBIO, Inc. | 7.225 |
Price Related Metrics
| PE Ratio | 50.39 |
| PS Ratio | 7.863 |
| PEG Ratio | 0.1489 |
| Price to Free Cash Flow | 27.50 |
| Earnings Yield | 1.98% |
| Market Cap | 517.53B |
| PEGY Ratio | 0.1479 |
| Operating PE Ratio | 21.73 |
| Normalized PE Ratio | 31.24 |